| Primary |
| Rib Fracture |
28.6% |
| Hypertension |
14.3% |
| Atrial Fibrillation |
9.5% |
| Back Pain |
4.8% |
| Blood Cholesterol |
4.8% |
| Dyslipidaemia |
4.8% |
| Gout |
4.8% |
| Musculoskeletal Pain |
4.8% |
| Neck Pain |
4.8% |
| Oedema Peripheral |
4.8% |
| Pain In Extremity |
4.8% |
| Peripheral Arterial Occlusive Disease |
4.8% |
| Renal Impairment |
4.8% |
|
| Vomiting |
50.0% |
| Hypertensive Crisis |
25.0% |
| Renal Failure Acute |
25.0% |
|
| Secondary |
| Osteoarthritis |
20.0% |
| Product Used For Unknown Indication |
18.4% |
| Hypertension |
10.1% |
| Rheumatoid Arthritis |
9.8% |
| Psoriatic Arthropathy |
6.1% |
| Pain |
4.8% |
| Atrial Fibrillation |
4.3% |
| Drug Use For Unknown Indication |
4.2% |
| Osteoporosis |
2.5% |
| Nasopharyngitis |
2.1% |
| Neuralgia |
2.1% |
| Pain In Extremity |
2.1% |
| Rotator Cuff Syndrome |
2.1% |
| Arthralgia |
1.9% |
| Back Pain |
1.9% |
| Spinal Cord Disorder |
1.9% |
| Ankylosing Spondylitis |
1.6% |
| Prostate Cancer |
1.5% |
| Dyslipidaemia |
1.4% |
| Gout |
1.3% |
|
| Osteonecrosis |
16.4% |
| Renal Failure Acute |
11.6% |
| Weight Increased |
9.6% |
| Vomiting |
8.2% |
| Melaena |
5.5% |
| Renal Failure Chronic |
5.5% |
| Stress |
4.8% |
| Allodynia |
4.1% |
| Nephrotic Syndrome |
4.1% |
| Suicide Attempt |
4.1% |
| Gastrointestinal Haemorrhage |
3.4% |
| Hepatitis Toxic |
3.4% |
| Nausea |
3.4% |
| Cerebrovascular Accident |
2.7% |
| Hepatitis Acute |
2.7% |
| Dry Mouth |
2.1% |
| Loss Of Consciousness |
2.1% |
| Myocardial Infarction |
2.1% |
| Pulmonary Arterial Hypertension |
2.1% |
| Self-medication |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.1% |
| Rheumatoid Arthritis |
21.5% |
| Drug Use For Unknown Indication |
9.3% |
| Pain |
7.1% |
| Ankylosing Spondylitis |
5.8% |
| Hypertension |
4.9% |
| Psoriatic Arthropathy |
4.5% |
| Osteoporosis |
3.2% |
| Prostate Cancer |
1.9% |
| Depression |
1.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Thrombosis Prophylaxis |
1.2% |
| Metastases To Bone |
1.2% |
| Prophylaxis |
1.1% |
| Arthritis |
1.0% |
| Psoriasis |
1.0% |
| Spondylitis |
1.0% |
| Diabetes Mellitus |
0.9% |
| Osteoarthritis |
0.9% |
| Pain Management |
0.8% |
|
| Vomiting |
10.3% |
| Pneumonia |
9.2% |
| Pyrexia |
6.5% |
| Pulmonary Embolism |
5.7% |
| Rheumatoid Arthritis |
5.7% |
| Weight Decreased |
5.7% |
| Pain |
5.4% |
| Nausea |
5.0% |
| Polyneuropathy |
4.6% |
| Rash |
4.6% |
| Thrombocytopenia |
4.6% |
| Urinary Tract Infection |
4.6% |
| Oedema Peripheral |
3.8% |
| Renal Impairment |
3.8% |
| Tachycardia |
3.8% |
| Arthralgia |
3.4% |
| Pleural Effusion |
3.4% |
| Somnolence |
3.4% |
| Death |
3.1% |
| Drug Ineffective |
3.1% |
|
| Interacting |
| Hypertension |
22.9% |
| Osteoarthritis |
7.6% |
| Diarrhoea |
7.1% |
| Rheumatoid Arthritis |
7.1% |
| Glaucoma |
5.3% |
| Musculoskeletal Discomfort |
5.3% |
| Neuroendocrine Tumour |
5.3% |
| Angioedema |
4.7% |
| Tongue Oedema |
4.7% |
| Arthralgia |
4.1% |
| Atrial Fibrillation |
3.5% |
| Product Used For Unknown Indication |
3.5% |
| Abdominal Pain |
2.4% |
| Back Pain |
2.4% |
| Benign Prostatic Hyperplasia |
2.4% |
| Cholecystectomy |
2.4% |
| Guillain-barre Syndrome |
2.4% |
| Insomnia |
2.4% |
| Nasopharyngitis |
2.4% |
| Rash |
2.4% |
|
| Visual Disturbance |
28.1% |
| Weight Decreased |
12.5% |
| Drug Interaction |
9.4% |
| International Normalised Ratio Increased |
6.3% |
| Renal Failure Acute |
6.3% |
| Antipsychotic Drug Level Increased |
3.1% |
| Dysarthria |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Haemorrhage |
3.1% |
| Hemiplegia |
3.1% |
| Hypertension |
3.1% |
| Hypochromic Anaemia |
3.1% |
| Pancytopenia |
3.1% |
| Renal Failure |
3.1% |
| Subcutaneous Haematoma |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Vasoconstriction |
3.1% |
|
